HCA Healthcare, Inc. $HCA Shares Sold by PKO Investment Management Joint Stock Co

PKO Investment Management Joint Stock Co reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 48.5% during the 2nd quarter, Holdings Channel reports. The fund owned 1,700 shares of the company’s stock after selling 1,600 shares during the quarter. PKO Investment Management Joint Stock Co’s holdings in HCA Healthcare were worth $651,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in HCA. ORG Partners LLC lifted its position in shares of HCA Healthcare by 27.9% during the second quarter. ORG Partners LLC now owns 142 shares of the company’s stock worth $55,000 after purchasing an additional 31 shares during the last quarter. Avantax Advisory Services Inc. lifted its position in shares of HCA Healthcare by 0.4% during the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company’s stock worth $2,791,000 after purchasing an additional 32 shares during the last quarter. Glenview Trust co lifted its holdings in HCA Healthcare by 2.3% in the first quarter. Glenview Trust co now owns 1,451 shares of the company’s stock worth $501,000 after acquiring an additional 32 shares during the last quarter. Horizon Investments LLC lifted its holdings in HCA Healthcare by 1.1% in the first quarter. Horizon Investments LLC now owns 3,175 shares of the company’s stock worth $1,097,000 after acquiring an additional 33 shares during the last quarter. Finally, Sivia Capital Partners LLC increased its stake in shares of HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.30% of the stock is owned by company insiders.

HCA Healthcare Trading Up 1.5%

HCA Healthcare stock opened at $446.58 on Friday. The company has a market capitalization of $104.50 billion, a P/E ratio of 18.77, a P/E/G ratio of 1.39 and a beta of 1.40. The firm’s fifty day simple moving average is $414.84 and its 200-day simple moving average is $381.67. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $461.56.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Analyst Ratings Changes

Several equities research analysts have commented on HCA shares. UBS Group raised their price target on shares of HCA Healthcare from $438.00 to $495.00 and gave the company a “buy” rating in a research note on Tuesday, October 14th. Royal Bank Of Canada lowered their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research note on Monday, July 28th. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Robert W. Baird raised their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Finally, Truist Financial set a $460.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $437.19.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.